Magnetic nanoparticles for drug delivery

M Arruebo, R Fernández-Pacheco, MR Ibarra… - Nano today, 2007 - Elsevier
Controlled release of drugs from nanostructured functional materials, especially
nanoparticles (NPs), is attracting increasing attention because of the opportunities in cancer …

Nanomedicine in the diagnosis and therapy of neurodegenerative disorders

AV Kabanov, HE Gendelman - Progress in polymer science, 2007 - Elsevier
Neurodegenerative and infectious disorders including Alzheimer's and Parkinson's
diseases, amyotrophic lateral sclerosis, and stroke are rapidly increasing as population's …

Targeted nanoparticle-based drug delivery and diagnosis

DF Emerich, CG Thanos - Journal of drug targeting, 2007 - Taylor & Francis
Nanotechnology, or systems/device manufacture at sizes generally ranging between 1 and
100 nm, is a multidisciplinary scientific field undergoing explosive development. The …

A Macrophage− Nanozyme delivery system for Parkinson's disease

EV Batrakova, S Li, AD Reynolds, RL Mosley… - Bioconjugate …, 2007 - ACS Publications
Selective delivery of antioxidants to the substantia nigra pars compacta (SNpc) during
Parkinson's disease (PD) can potentially attenuate oxidative stress and as such increase …

Liposome–nanoparticle hybrids for multimodal diagnostic and therapeutic applications

WT Al-Jamal, K Kostarelos - Nanomedicine, 2007 - Taylor & Francis
Liposomes have a decade-long clinical presence as nanoscale delivery systems of
encapsulated anthracycline molecules. However, their use as delivery systems of …

[PDF][PDF] Self-assembled surfactant nano-structures important in drug delivery: a review

GH Sagar, MA Arunagirinathan, JR Bellare - 2007 - nopr.niscpr.res.in
Role of self assembled structures as a vehicle is significant over the years. Their
applications have been found for all routes of drug delivery. These micro and nano …

Surface modification of RGD-liposomes for selective drug delivery to monocytes/neutrophils in brain

J Qin, D Chen, HY Hu, Q Cui, M Qiao… - Chemical and …, 2007 - jstage.jst.go.jp
In the present study, RGD peptide was coupled with ferulic acid (FA) liposomes for binding
to monocytes and neutrophils in peripheral blood for brain targeting in response to leukocyte …

Effects of targeting magnetic drug nanoparticles on human cholangiocarcinoma xenografts in nude mice.

T Tang, JW Zheng, B Chen, H Li, X Li… - Hepatobiliary & …, 2007 - europepmc.org
Background Targeting is a new therapeutic tool for malignant tumor as a result of combining
nanotechnology with chemotherapeutics. The aim of our study was to investigate the effects …

Body distributioin of RGD-mediated liposome in brain-targeting drug delivery

J Qin, D Chen, HY Hu, MX Qiao, X Zhao, B Chen - Yakugaku Zasshi, 2007 - jstage.jst.go.jp
RGD conjugation liposomes (RGD-liposomes) were evaluated for brain-targeting drug
delivery. The‰ ow cytometric in vitro study demonstrated that RGD-liposomes could bind to …

纳米磁小体靶向药囊治疗人胆管癌细胞株移植瘤实验研究

唐滔, 郑建伟, 李曦, 艾星, 邹声泉 - 外科理论与实践, 2007 - cqvip.com
目的: 将纳米磁小体靶向药囊(TM5-FUNC) 经尾静脉注射人胆管癌荷瘤裸鼠体内,
通过埋植在移植瘤内的磁化支架所产生的磁靶向引导作用, TM5-FUNC 选择性地聚集于裸鼠 …